KENYA—Revital Healthcare EPZ Ltd, based in Kenya and one of Africa’s major producers of medical disposable products, has opened Africa’s largest cutting-edge  Rapid Diagnostics Test kits (RDTs) manufacturing  plant in Kikambala, Kilifi South.

The launch of this facility marks a significant step forward in Kenya’s pharmaceutical manufacturing scene, as the company expands its supply chain and local manufacturing capabilities.

With co-funding from USAID of  over US$2 million , the Revital EPZ’s pioneering effort will improve healthcare access across borders and develop production capacity to produce 240 million RDTs  annually.

The new facility will pioneer the production of critical diagnostic items for HIV, Malaria, Hepatitis B/C, and Syphilis, among others.

This will not only increase local availability of these devices, but will also establish Kenya as a regional manufacturing hub for health products and technology (HPTs).

Furthermore, the facility is planned to develop skilled labor and create significant employment prospects for Kilifi locals.

This initiative is part of President William Ruto’s strategy to advance local manufacturing. Its goal is to reduce dependency on imported Active Pharmaceutical Ingredients (APIs) while encouraging cross-sector collaboration.

The move comes as the Africa CDC is revising its Partnership for Vaccine Manufacturing, with the goal of producing 60% of the continent’s vaccine needs by 2040.

This push is critical in ensuring that Africa can improve its procurement and supply chain systems, with a particular focus on childhood immunization efforts across the continent, laying the groundwork for resilient and self-sufficient health systems that allow people to access and use health commodities as needed.

Notable dignitaries attended the launch, including the United States Ambassador to Kenya, Meg Whitman, Health Cabinet Secretary Susan Nakhumicha, Kilifi County Governor Gideon Mung’aro, and Dr. Juma Mukhwana, Principal Secretary for the State Department of Industry, among others, emphasising the global significance of this milestone in healthcare innovation.

Speaking at the event, CS Nakhumincha praised Revital Healthcare for their initiative, which is consistent with H.E President Dr. William Ruto’s commitment to supporting local manufacturing as part of the Bottom-Up Economic Transformation Agenda.

She also stated that the establishment of this facility is in response to the need for a responsive supply chain that would ensure the availability and access to HPTs, which are important to the implementation of Universal Health Coverage.

She went on to say that as a Ministry, they are committed to securing HPTs at more affordable prices, supporting local manufacture, and streamlining their public health procurement methods to improve efficiency.

For his part, Governor Munga’ro of Kilifi County expressed his commitment to ensuring that their investors and partners receive consistent support in creating a favorable climate for the security and prosperity of their ventures.

He went on to acknowledge and appreciate the positive impact of the partnership with the US government, notably in the field of healthcare.

Ambassador Whitman supported Governor Mungaro’s sentiments, stating that Revital Kenya was doing an exceptional job supplying affordable, high-quality healthcare supplies to Africa while also creating jobs for Kenyans.

Dr. Juma Mukhwana, Principal Secretary for the State Department of Industry, spoke on behalf of Cabinet Secretary for Investments, Trade, and Industry Rebecca Miano, emphasising Kenya’s potential as a pharmaceutical manufacturing hub.

He urged local manufacturers to capitalize on the opportunity provided by President Ruto’s government.

Revital Healthcare has emerged as a pathfinder in East and Central Africa, producing crucial medical devices that manage respiratory issues in neonates and infants without the need for electricity.

Revital’s breakthrough has far-reaching consequences for pediatric healthcare, as respiratory distress kills about 1.1 million neonates worldwide each year.

Early in February, the company received World Health Organization (WHO) Prequalification for its auto-disabled (AD) products, becoming the first East and Central African company to manufacture medical devices .

This has led the company to become one of the major producers of medical disposable products in Africa, with a product portfolio of 48 medical devices and exports to over 28 countries worldwide.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.